NSE ScannerInsurance · Life/Health Insurance · NSE: NIVABUPA · data 2026-11-01
Niva Bupa Health Insurance Company Limited
In plain words
Price: 20.5% below its 52-week high of ₹91.4.
Delivery: 66.0% of traded shares were kept for delivery over the last 10 sessions, against 55.0% over the last 60.
Latest results: a net profit of ₹345 cr for the quarter ended Mar 2026 (+67.5% on the same quarter a year earlier).
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹6,853 cr |
| Net profit (last 12 months) | ₹360 cr |
| Sales growth, 3 years (yearly) | 37.8% |
| Profit growth, 3 years (yearly) | 250.4% |
At a glance
Promoters 55.3% (-0.1 pts in a year), pledged 0.0%, institutions 28.8%.
P/E 37.6, P/B 3.5, dividend yield 0.0%. Price relative to earnings and book value (low is cheaper, not better).
ROE 10.0%, operating margin 5.5%: how much profit it earns on the money it uses.
Profit growth 250.4% and sales growth 37.8% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
- Profit grew 250.4% a year over 3 years.
None flagged by these rules.
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Latest results in brief (Q4 FY26)
NIVABUPA Q4 FY26 results (standalone figures, as filed on NSE).
Income was ₹1,971.95 crore, up 29.1% YoY and up 35.7% QoQ.
Net profit was ₹345.13 crore, up 67.5% YoY and a turn to profit from a loss last quarter.
EPS was ₹1.87, up 65.5% YoY and positive against a negative EPS last quarter.
NIVABUPA के Q4 FY26 नतीजे (स्टैंडअलोन आंकड़े, NSE पर दाखिल)।
आय: ₹1,971.95 करोड़; पिछले साल की तुलना में 29.1% की बढ़त, पिछली तिमाही की तुलना में 35.7% की बढ़त।
शुद्ध मुनाफ़ा: ₹345.13 करोड़; पिछले साल की तुलना में 67.5% की बढ़त, पिछली तिमाही के घाटे से मुनाफ़े में आया।
EPS: ₹1.87; पिछले साल की तुलना में 65.5% की बढ़त, पिछली तिमाही के ऋणात्मक EPS से धनात्मक हुआ।
NIVABUPAના Q4 FY26 પરિણામો (સ્ટેન્ડઅલોન આંકડા, NSE પર ફાઇલ કરેલા).
આવક: ₹1,971.95 કરોડ; ગયા વર્ષની સરખામણીએ 29.1% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 35.7% વધારો.
ચોખ્ખો નફો: ₹345.13 કરોડ; ગયા વર્ષની સરખામણીએ 67.5% વધારો, ગયા ક્વાર્ટરની ખોટમાંથી નફામાં આવી.
EPS: ₹1.87; ગયા વર્ષની સરખામણીએ 65.5% વધારો, ગયા ક્વાર્ટરના નકારાત્મક EPSથી હકારાત્મક થઈ.
Written from the filed numbers. Not a recommendation.
Smart-money activity
18/100 · Weak over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 6/30: Delivery 44.8% over the last 20 sessions vs 57.1% in the 40 before (0.78x); shares delivered per day 1.34x usual; 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 7/15: 3 schemes hold it, about ₹474 cr in all (as of 2026-09-30). Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Results
- 8 May 26Results Q4 FY26 results: profit +67.5% YoY +5.3% next session
- 29 Jan 26Results Q3 FY26 results: net profit −₹87.6 cr +2.4% next session
- 3 Nov 25Results Q2 FY26 results: net profit −₹35.3 cr +1.8% next session
- 31 Jul 25Results Q1 FY26 results: net profit −₹91.4 cr -4.3% next session
- 8 May 25Results Q4 FY25 results: net profit ₹206.1 cr +7.0% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Quarterly results (standalone)
| Quarter | Revenue | Net profit | Profit YoY | Op. margin | EPS ₹ |
|---|---|---|---|---|---|
| Mar 2026 | ₹1,972 cr | ₹345 cr | +67.5% | — | 1.87 |
| Dec 2025 | ₹1,454 cr | ₹-88 cr | — | — | -0.47 |
| Sept 2025 | ₹1,422 cr | ₹-35 cr | — | — | -0.19 |
| Jun 2025 | ₹1,220 cr | ₹-91 cr | — | — | -0.5 |
Shareholding trend
| Holder | Sept 2026 | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|---|
| Promoters | 55.29% | 55.30% | 55.36% | 55.36% |
| Foreign institutions (FII) | 12.95% | 12.09% | 10.60% | 10.32% |
| Domestic institutions (DII) | 15.89% | 16.17% | 16.49% | 16.04% |
| Mutual funds | 9.19% | 9.35% | 9.80% | 9.31% |
| Retail investors | 1.76% | 1.92% | 2.19% | 2.57% |
| Number of shareholders | 1,20,607 | 1,26,567 | 1,35,343 | 1,47,718 |
Common questions
What was Niva Bupa Health Insurance Company Limited's latest quarterly profit?
Niva Bupa Health Insurance Company Limited reported a net profit of ₹345 cr for the quarter ended Mar 2026 (+67.5% on the same quarter a year earlier), on revenue of ₹1,972 cr.
How much do promoters hold in Niva Bupa Health Insurance Company Limited?
Promoters held 55.29% of Niva Bupa Health Insurance Company Limited at the end of Sept 2026, with 0.00% of promoter shares pledged.
Is Niva Bupa Health Insurance Company Limited debt-free?
Its latest reported debt-to-equity ratio is 0.1.
What is Niva Bupa Health Insurance Company Limited's P/E ratio?
About 37.6, based on the last 12 months' earnings and a price of ₹72.65 (data 2026-11-01).
What is the 52-week high and low of Niva Bupa Health Insurance Company Limited?
The 52-week high is ₹91.4 and the 52-week low is ₹67.5.
Mutual funds holding Niva Bupa Health Insurance Company Limited
From the monthly portfolios of the fund houses the site reads, as of 2026-09-30. 3 schemes holding about ₹474 cr; funds that hold it outside their top holdings may not be listed.
| Scheme | Fund house | % of fund | Value |
|---|---|---|---|
| Nippon India Multi Cap Fund | Nippon India Mutual Fund | 0.71% | ₹382 cr |
| SBI Banking And Financial Services Fund | SBI Mutual Fund | 0.65% | ₹68 cr |
| Nippon India Innovation Fund | Nippon India Mutual Fund | 0.83% | ₹24 cr |
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| Niva Bupa Health Insurance Company Limited | ₹72.65 | ₹13,432 cr | 37.6 | 3.5 | 10% | 9.8% | 0.1 | -3.5% |
| HDFC Life Insurance Co. Ltd. | ₹524.9 | ₹1,13,659 cr | 55.4 | 5.9 | 11.3% | 0.6% | 0.17 | -30.8% |
| ICICI Life Insurance Ltd | ₹410 | ₹59,356 cr | 37.1 | 4.4 | 12.6% | 0.6% | 0.19 | -31.8% |
| Max Financial Services Limited | ₹1,200 | ₹41,517 cr | 221.9 | 7.2 | 1.6% | — | 0.44 | -21.0% |
| Star Health & Allied Insurance Co. Ltd. | ₹530.4 | ₹31,215 cr | 29.7 | 3 | 7.6% | 4.6% | 0.06 | +10.3% |
| Canara HSBC Life Insurance Company Limited | ₹121.41 | ₹11,519 cr | 36 | 7 | 8.1% | 0.2% | 0.16 | +3.8% |
Compare NIVABUPA with HDFCLIFE in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open NIVABUPA in NSE Scanner →